Together with AniCura’s preferred diagnostic supplier, AniCura performed analyses of pre-anesthetic testing and invested in in-house laboratory equipment. These initiatives can help improve patient safety.
The following two examples from AniCura Denmark and AniCura Netherlands illustrate AniCura’s strong focus on improving the quality of laboratory services.
What is the value of pre-anesthetic blood testing?
Three Anicura hospitals in Denmark tested the outcome of pre-anesthetic screening on 100 cats and 100 dogs undergoing anesthesia for elective dental treatments.
The mean age of the dogs was 6.5 years. 9% of the dogs had severe abnormalities to a degree where anesthesia was either postponed or altered. 36% had one or more mild abnormality that would warrant a follow-up. The mean age of the cats was 9.3 years. 33% of the cats had severe abnormalities and 35% had mild abnormalities - leaving a small fraction of the screened cats completely normal. 15% of the cats had abnormal natriuretic peptide levels indicating increased stress to the heart, two cats had high total thyroxine concentration and, in both cases, the results were unexpected.
This indicates that apart from giving us a go or no-go for anesthesia, pre-anesthetic testing can help us discover problems early and act as an important tool in preventive care.
Faster results equals earlier treatment
At the end of 2020, AniCura Netherlands made a significant investment in in-house diagnostics and found two results:
A trend of shifting from external lab to in-house diagnostics as well as an increase in the total amount of testing. This has a direct positive impact for pets and pet owners. With more diagnosed animals and faster results, appropriate treatment can begin sooner, thus improving the quality of life for pets.